RxDoctor Payments Data

Michael Adler, DO

Physical Medicine & Rehabilitation · Flushing, NYNPI 1043408719

Payments from drug & device makers

$1,428in general payments, 2019–2025

Across 74 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$428
  • Collegium Pharmaceutical, Inc.$208
  • Sentynl Therapeutics, Inc.$140
  • Redhill Biopharma Inc.$137
  • Daiichi Sankyo Inc.$126
  • Orexo US, Inc.$72
  • plus $316 from 11 others

What the payments were for

  • Food & beverage$1,40799%
  • Education$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,428 in reported general payments places this provider in the 80th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$189,292
Medicare patients
247
Services billed
1,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl70$117,915
Budesonide ErBudesonide53$56,437
Xtampza ErOxycodone Myristate14$31,767
Nucynta ErTapentadol Hcl20$30,422
Diclofenac Sodium103$23,547
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl92$23,379
ZubsolvBuprenorphine Hcl/Naloxone Hcl15$10,972
Naproxen Sodium CrNaproxen Sodium21$8,452
Diclofenac Epolamine12$6,887
BelbucaBuprenorphine Hcl13$6,502
Tramadol Hcl120$2,688
Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12)52$2,423
Fentanyl24$2,306
Morphine Sulfate ErMorphine Sulfate41$2,285
Lidocaine20$1,839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er, Nucynta Er, Belbuca$208$186,606117 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate$59$24,772146 claims
Orexo US, Inc.Zubsolv$72$10,97215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Flushing

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →